Strategic partnerships PreventionGenetics has a track record of collaborating with biotech and healthcare organizations (e.g., Rhythm Pharmaceuticals, Foundation Fighting Blindness, Security Health Plan). This suggests fertile ground for new alliance deals, co-development, or value-based testing programs with pharma, vision research groups, and payer partnerships.

Expanded test portfolio With PGnome (WGS) and PGxome (WES) and a stated focus on expanding test menus and adopting new technologies, there are opportunities to upsell comprehensive genomic testing to clinics and research institutions seeking broader or deeper sequencing insights, including germline panels and diagnostic extensions.

Global reach potential Accreditation (CLIA, ISO 15189:2012) and world-wide service focus position PreventionGenetics for international labs and researchers seeking compliant, high-quality genetic testing, offering cross-border turnkey solutions, partnerships, and managed services.

Cost and value Pricing emphasis paired with payer-friendly arrangements (e.g., potential premium on efficiency and reduced medical claims expenses) indicates sales opportunities around affordable testing programs, bundled services, and payer-approved pathways that drive adoption and loyalty.

Digital engagement A tech stack including Google Ads, Pardot, DocuSign, and cloud tools signals readiness for targeted digital selling, marketing automation, and streamlined contracting, enabling outbound campaigns, secure e-commerce, and scalable client onboarding.